Suppr超能文献

9p21.3 基因变异对早发心肌梗死患者临床及血管造影结局的影响。

Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction.

机构信息

Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

出版信息

J Am Coll Cardiol. 2011 Jul 19;58(4):426-34. doi: 10.1016/j.jacc.2010.11.075.

Abstract

OBJECTIVES

The purpose of this study was to test whether the 9p21.3 variant rs1333040 influences the occurrence of new cardiovascular events and coronary atherosclerosis progression after early-onset myocardial infarction.

BACKGROUND

9p21.3 genetic variants are associated with ischemic heart disease, but it is not known whether they influence prognosis after an acute coronary event.

METHODS

Within the Italian Genetic Study of Early-onset Myocardial Infarction, we genotyped rs1333040 in 1,508 patients hospitalized for a first myocardial infarction before the age of 45 years who underwent coronary angiography without index event coronary revascularization. They were followed up for major cardiovascular events and angiographic coronary atherosclerosis progression.

RESULTS

Over 16,599 person-years, there were 683 cardiovascular events and 492 primary endpoints: 77 cardiovascular deaths, 223 reoccurrences of myocardial infarction, and 383 coronary artery revascularizations. The rs1333040 genotype had a significant influence (p = 0.01) on the primary endpoint, with an adjusted hazard ratio of 1.19 (95% confidence interval [CI]: 1.08 to 1.37) for heterozygous carriers and 1.41 (95% CI: 1.06 to 1.87) for homozygous carriers. Analysis of the individual components of the primary endpoints provided no significant evidence that the rs1333040 genotype influenced the hazard of cardiovascular death (p = 0.24) or the reoccurrence of myocardial infarction (p = 0.57), but did provide significant evidence that it influenced on the hazard of coronary revascularization, with adjusted heterozygous and homozygous ratios of 1.38 (95% CI: 1.17 to 1.63) and 1.90 (95% CI: 1.36 to 2.65) (p = 0.00015), respectively. It also significantly influenced the angiographic endpoint of coronary atherosclerosis progression (p = 0.002).

CONCLUSIONS

In early-onset myocardial infarction, the 9p21.3 variant rs1333040 affects the progression of coronary atherosclerosis and the probability of coronary artery revascularization during long-term follow-up.

摘要

目的

本研究旨在检验 9p21.3 变异 rs1333040 是否会影响早发心肌梗死患者新发心血管事件和冠状动脉粥样硬化进展。

背景

9p21.3 基因变异与缺血性心脏病相关,但尚不清楚其是否会影响急性冠脉事件后的预后。

方法

在意大利早发心肌梗死遗传研究中,我们对 1508 名 45 岁以下因首次心肌梗死住院且未接受指数事件冠状动脉血运重建的患者进行了 rs1333040 基因分型。随访主要心血管事件和血管造影冠状动脉粥样硬化进展情况。

结果

在 16599 人年中,共发生 683 例心血管事件和 492 例主要终点事件:77 例心血管死亡,223 例心肌梗死再发,383 例冠状动脉血运重建。rs1333040 基因型对主要终点事件有显著影响(p=0.01),杂合携带者的校正风险比为 1.19(95%置信区间:1.08 至 1.37),纯合携带者为 1.41(95%置信区间:1.06 至 1.87)。对主要终点事件各组成部分的分析未提供 rs1333040 基因型显著影响心血管死亡风险(p=0.24)或心肌梗死再发风险(p=0.57)的证据,但提供了显著证据表明其影响冠状动脉血运重建的风险,校正后的杂合子和纯合子比值分别为 1.38(95%置信区间:1.17 至 1.63)和 1.90(95%置信区间:1.36 至 2.65)(p=0.00015)。它还显著影响血管造影冠状动脉粥样硬化进展终点(p=0.002)。

结论

在早发心肌梗死中,9p21.3 变异 rs1333040 影响冠状动脉粥样硬化的进展以及长期随访期间冠状动脉血运重建的概率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验